(Q42070313)

16 October 2017

title

Oral Labetalol Versus Oral Clonidine in the Emergency Treatment of Severe Hypertension (English)

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

10 November 2022

author name string

Soto-Greene ML

6

1 reference

16 October 2017

S. H. Atkin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

M. A. Jaker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

P. Beaty

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

M. A. Quadrel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

C. Cuffie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

M. L. Soto-Greene

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728876

10 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

full work available at URL

16 October 2017

https://api.elsevier.com/content/article/PII:S0002962915357761?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

https://api.elsevier.com/content/article/PII:S0002962915357761?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

American Journal of the Medical Sciences

10 November 2022

published in

1 reference

16 October 2017

volume

303

1 reference

16 October 2017

issue

1

1 reference

16 October 2017

page(s)

9-15

1 reference

Immediate treatment of severe hypertension. Widening the options

16 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Treatment of hypertensive crisis

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

How urgent is 'urgent' hypertension?

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Acute reduction of blood pressure in asymptomatic patients with severe hypertension. An idea whose time has come--and gone

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Hypertensive emergencies and urgencies

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Management of urgent hypertension: a comparison of oral treatment regimens in the emergency department

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Oral clonidine loading in hypertensive urgencies

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Treatment of hypertensive urgencies and emergencies with nifedipine

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

New approaches for the treatment of hypertensive urgencies and emergencies

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Intravenous labetalol in the management of severe hypertension and hypertensive emergencies

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Clinical Evaluation of Intravenous Labetalol for the Treatment of Hypertensive Urgency

10 November 2022

21

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

The effects of single-dose atenolol, labetalol, and propranolol on cardiac and vascular function.

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

10 November 2022

Drugs Five Years Later

26

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Clonidine hydrochloride: review of pharmacologic and clinical aspects

10 November 2022

27

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Rapid onset of action of oral labetalol in severe hypertension

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Acute management of severe hypertension with oral labetalol

10 November 2022

30

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Rate of onset of hypotensive effect of oral labetalol

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Oral labetalol in the urgent treatment of severe hypertension

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Oral clonidine loading for rapid control of hypertension

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Oral clonidine for rapid control of accelerated hypertension.

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1097/00000441-199201000-00004

10 November 2022

Identifiers

1 reference

16 October 2017

1 reference